Literature DB >> 20688906

Probabilistic (Bayesian) modeling of gene expression in transplant glomerulopathy.

Eric A Elster1, Jason S Hawksworth, Orlena Cheng, David B Leeser, Michael Ring, Douglas K Tadaki, David E Kleiner, John S Eberhardt, Trevor S Brown, Roslyn B Mannon.   

Abstract

Transplant glomerulopathy (TG) is associated with rapid decline in glomerular filtration rate and poor outcome. We used low-density arrays with a novel probabilistic analysis to characterize relationships between gene transcripts and the development of TG in allograft recipients. Retrospective review identified TG in 10.8% of 963 core biopsies from 166 patients; patients with stable function were studied for comparison. The biopsies were analyzed for expression of 87 genes related to immune function and fibrosis by using real-time PCR, and a Bayesian model was generated and validated to predict histopathology based on gene expression. A total of 57 individual genes were increased in TG compared with stable function biopsies (P < 0.05). The Bayesian analysis identified critical relationships between ICAM-1, IL-10, CCL3, CD86, VCAM-1, MMP-9, MMP-7, and LAMC2 and allograft pathology. Moreover, Bayesian models predicted TG when derived from either immune function (area under the curve [95% confidence interval] of 0.875 [0.675 to 0.999], P = 0.004) or fibrosis (area under the curve [95% confidence interval] of 0.859 [0.754 to 0.963], P < 0.001) gene networks. Critical pathways in the Bayesian models were also analyzed by using the Fisher exact test and had P values <0.005. This study demonstrates that evaluating quantitative gene expression profiles with Bayesian modeling can identify significant transcriptional associations that have the potential to support the diagnostic capability of allograft histology. This integrated approach has broad implications in the field of transplant diagnostics.

Entities:  

Mesh:

Year:  2010        PMID: 20688906      PMCID: PMC2928430          DOI: 10.2353/jmoldx.2010.090101

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  44 in total

Review 1.  Cellular and molecular parameters in human renal allograft rejection.

Authors:  M Kamoun
Journal:  Clin Biochem       Date:  2001-02       Impact factor: 3.281

Review 2.  Biomarkers and surrogate endpoints in renal transplantation: present status and considerations for clinical trial design.

Authors:  Peter A Lachenbruch; Amy S Rosenberg; Ezio Bonvini; Marc W Cavaillé-Coll; Robert B Colvin
Journal:  Am J Transplant       Date:  2004-04       Impact factor: 8.086

3.  Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era.

Authors:  Herwig-Ulf Meier-Kriesche; Jesse D Schold; Titte R Srinivas; Bruce Kaplan
Journal:  Am J Transplant       Date:  2004-03       Impact factor: 8.086

4.  Messenger RNA for FOXP3 in the urine of renal-allograft recipients.

Authors:  Thangamani Muthukumar; Darshana Dadhania; Ruchuang Ding; Catherine Snopkowski; Rubina Naqvi; Jun B Lee; Choli Hartono; Baogui Li; Vijay K Sharma; Surya V Seshan; Sandip Kapur; Wayne W Hancock; Joseph E Schwartz; Manikkam Suthanthiran
Journal:  N Engl J Med       Date:  2005-12-01       Impact factor: 91.245

5.  Predicting subsequent decline in kidney allograft function from early surveillance biopsies.

Authors:  Fernando G Cosio; Joseph P Grande; Hani Wadei; Timothy S Larson; Matthew D Griffin; Mark D Stegall
Journal:  Am J Transplant       Date:  2005-10       Impact factor: 8.086

6.  Functionally significant renal allograft rejection is defined by transcriptional criteria.

Authors:  Steven C Hoffmann; Douglas A Hale; David E Kleiner; Roslyn B Mannon; Robert L Kampen; Lynn M Jacobson; Linda C Cendales; S John Swanson; Bryan N Becker; Allan D Kirk
Journal:  Am J Transplant       Date:  2005-03       Impact factor: 8.086

7.  Relationship of transforming growth factor-beta(1) with tumour necrosis factor-alpha and endothelial activation in patients with stable renal transplantation.

Authors:  Alessandro Palermo; Giuseppe Mulè; Anna Vadalà; Francesco Vaccaro; Marco Guarneri; Rosalia Arsena; Chiara Briolotta; Giovanni Cerasola; Santina Cottone
Journal:  Nephrology (Carlton)       Date:  2008-04       Impact factor: 2.506

8.  Transplant glomerulopathy may occur in the absence of donor-specific antibody and C4d staining.

Authors:  Enver Akalin; Rajani Dinavahi; Steven Dikman; Graciela de Boccardo; Rex Friedlander; Bernd Schroppel; Vinita Sehgal; Jonathan S Bromberg; Peter Heeger; Barbara Murphy
Journal:  Clin J Am Soc Nephrol       Date:  2007-10-17       Impact factor: 8.237

9.  Regulatory functions of alloreactive Th2 clones in human renal transplant recipients.

Authors:  Joana E Kist-van Holthe; Martin Gasser; Karl Womer; Nader Najafian; Victor Dong; Dimitry V Samsonov; Chris S Geehan; Anil Chandraker; Mohamed H Sayegh; Ana Maria Waaga
Journal:  Kidney Int       Date:  2002-08       Impact factor: 10.612

10.  Molecular and immunohistochemical characterization of the onset and resolution of human renal allograft ischemia-reperfusion injury.

Authors:  Steven C Hoffmann; Robert L Kampen; Shashi Amur; Muhammad A Sharaf; David E Kleiner; Keith Hunter; S John Swanson; Douglas A Hale; Roslyn B Mannon; Patrick J Blair; Allan D Kirk
Journal:  Transplantation       Date:  2002-10-15       Impact factor: 4.939

View more
  4 in total

Review 1.  Matrix metalloproteinases in kidney homeostasis and diseases.

Authors:  Roderick J Tan; Youhua Liu
Journal:  Am J Physiol Renal Physiol       Date:  2012-04-04

2.  The clinical and genomic significance of donor-specific antibody-positive/C4d-negative and donor-specific antibody-negative/C4d-negative transplant glomerulopathy.

Authors:  Nicole Hayde; Yi Bao; James Pullman; Bin Ye; R Brent Calder; Monica Chung; Daniel Schwartz; Michelle Lubetzky; Maria Ajaimy; Graciela de Boccardo; Enver Akalin
Journal:  Clin J Am Soc Nephrol       Date:  2013-09-12       Impact factor: 8.237

3.  Integrative Analyses of Circulating Small RNAs and Kidney Graft Transcriptome in Transplant Glomerulopathy.

Authors:  Canan Kuscu; Manjari Kiran; Akram Mohammed; Cem Kuscu; Sarthak Satpathy; Aaron Wolen; Elissa Bardhi; Amandeep Bajwa; James D Eason; Daniel Maluf; Valeria Mas; Enver Akalin
Journal:  Int J Mol Sci       Date:  2021-06-09       Impact factor: 5.923

4.  Glomerulocapillary miRNA response to HLA-class I antibody in vitro and in vivo.

Authors:  Falko M Heinemann; Peter T Jindra; Clemens L Bockmeyer; Philip Zeuschner; Juliane Wittig; Heike Höflich; Marc Eßer; Mahmoud Abbas; Georg Dieplinger; Katharina Stolle; Udo Vester; Peter F Hoyer; Stephan Immenschuh; Andreas Heinold; Peter A Horn; Wentian Li; Ute Eisenberger; Jan U Becker
Journal:  Sci Rep       Date:  2017-11-06       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.